Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

More Power For MedPAC? Obama Likes The Idea

Executive Summary

President Obama is throwing his support behind the concept of giving MedPAC the power to make coverage and reimbursement decisions for Medicare

You may also be interested in...



Health Reform Magnifies Payers' Invisible Place At The Licensing Table

Report from Licensing Executives Society meeting: Survey shows many already have taken action oncomparative effectiveness.

Obama Assures AMA That CER Will Offer Information, Not “Dictate” Medical Choices

President reiterates his recent proposal to save $75 billion from “more efficient purchasing” of Part D drugs.

Medicare Reimbursement Rates Would Be Set By New MedPAC Agency In Bill

Sen. Jay Rockefeller, D-W.Va., has adapted the concept of establishing an independent federal health care board modeled on the Federal Reserve in new legislation: his bill S. 1110 would convert the Medicare Payment Advisory Commission into an executive branch agency with expanded responsibilities

Topics

UsernamePublicRestriction

Register

ID007083

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel